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Abstract 
An effective, specific and accurate method is presented for the quantification of 13 markers 
of anthropogenic contaminants in water using solid phase extraction (SPE) followed by high 
performance liquid chromatography (HPLC) tandem mass spectrometry (MS/MS). 
Validation was conducted according to the International Conference on Harmonisation (ICH) 
guidelines. Method recoveries ranged from 77-114% and limits of quantification between 
0.75-4.91 ng/L. A study was undertaken to quantify the concentrations and loadings of the 
selected contaminants in 6 sewage treatment works (STW) effluent discharges as well as 
concentrations in 5 rain-driven street runoffs and field drainages. Detection frequencies in 
STW effluent ranged from 25% (ethinylestradiol) to 100% (benzoylecgonine, bisphenol-A 
(BPA), bisphenol-S (BPS) and diclofenac). Average concentrations of detected compounds in 
STW effluents ranged from 3.62 ng/L (ethinylestradiol) to 210 ng/L (BPA). Levels of 
perfluorinated compounds (PFCs) perfluorooctanoic acid (PFOA) and perfluorononanoic 
acid (PFNA) as well as the plasticiser BPA were found in street runoff at maximum levels of 
1160 ng/L, 647 ng/L and 2405 ng/L respectively (8.52, 3.09 and 2.7 times more concentrated 
than maximum levels in STW effluents respectively). Rain-driven street runoff may have an 
effect on levels of PFCs and plasticisers in receiving rivers and should be further 
investigated. Together, this method with the 13 selected contaminants enables the 
quantification of various markers of anthropogenic pollutants: inter alia pharmaceuticals, 
illicit drugs and their metabolites from humans and improper disposal of drugs, while the 
plasticisers and perfluorinated compounds may also indicate contamination from industrial 
and transport activity (street runoff).  
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1. Introduction 
From the turn of the 21st century, the occurrence, fate and environmental toxicity of 
pharmaceuticals and other so-called emerging contaminants in the aquatic environment 
(rivers, reservoirs, oceans and drinking water) has been the subject of many studies (e.g., 
Kolpin et al., 2002; Vajda et al., 2008; 2011; Llorca et al. 2012) and reviews (e.g., Petrie et 
al., 2015; Wilkinson et al., 2015). Nearly every human and veterinary pharmaceutical has 
been detected in the aquatic environment, typically at sub-µg/L concentrations. Evidence 
suggests that once in the aquatic environment, residues of some pharmaceuticals and other 
emerging contaminants (ECs) cause biological disruption/dysfunction in exposed non-target 
organisms via mechanisms such as endocrine dysfunction (Woodling et al., 2006; Vajda et 
al., 2008; Patisaul et al., 2009; Vajda et al., 2011). Once administered, pharmaceuticals are 
rarely, if ever, completely metabolised in the body and are directed to sewage treatment 
works (STWs) via urinary and biliary fecal excretions (Jjemba, 2006; Silva et al., 2011). 
Residues of pharmaceuticals typically enter the aquatic environment through STW effluent 
outfalls where many compounds do not completely degrade (Verlicchi et al., 2012). Other 
anthropogenic contaminants such as musk compounds used in fragrances and lotions, 
surfactants, and ultraviolet filters in sunscreen are also directed to STWs via wastewater 
(Peck, 2006; Roosens et al., 2007). Supplementary Table 1 shows concentrations of 21 
pharmaceuticals and other emerging contaminants which are typically detected in river water.  
Emerging contaminants are commonly defined as any compound (both synthetic and 
natural) in the environment whose presence is not routinely monitored and shows the 
potential to cause ecological disruption (Raghav et al., 2013; United States Geological 
Survey, 2014). Among such ECs are perfluorinated compounds (PFCs) such as 
perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorobutane sulfonic 
acid (PFBS), and perfluorooctane sulfonate (PFOS) as well as plasticisers including 
bisphenol-A (BPA) and bisphenol-S (BPS) among others. Plasticisers are commonly used to 
modify the rigidity of plastic materials and are used in product and food packaging, 
manufacture of polycarbonate plastic, thermal receipt paper, water pipes, epoxy resins, vinyl 
floors, car tires, among many others (U.S. Food and Drug Administration, 2015). 
Perfluorinated compounds are commonly used in waterproofing agents, polishes, waxes, non-
stick cookware and cleaning products (Posner, 2012). ECs such as plasticisers and PFCs are 
also known to enter the aquatic environment through STW effluent outfalls (Meyer and 
Bester, 2004; Zhang et al., 2013). 
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Biodegradation of PFC precursor molecules during sewage treatment into other PFCs 
is suggested to increase their effluent concentrations by 32-290 times over that in the influent 
(Zhang et al., 2013). For example, Zhang et al. (2013) reported that of 28 sampled STWs in 
economically developed areas of China, effluent concentrations of PFOA were higher than 
influent 81% of the time, 69% of the time for perfluorononanoic acid (PFNA), 57% of the 
time for perfluorobutane sulfonic acid (PFBS) and 58% of the time for PFOS. Precursor 
molecules found in STW influent include N-ethyl perfluorooctane sulphonamide, which 
degrades into PFOS and fluorotelomer alcohols (e.g., 8:2 fluorotelomer alcohol) which 
degrade into PFOA (Zhang et al., 2012; Avendaño and Liu, 2015).  
Recent evidence indicates that PFCs may be introduced into the aquatic environment 
through non-point sources, such as runoff from streets (Zushi et al., 2008; Murakami et al., 
2009; Furl et al., 2011). Zushi et al. (2008) reported concentrations of PFCs 2-11 times higher 
in rain runoff than in the effluent outfalls of three studied STWs along the Tsurumi River 
(Yokohama City, Kanagawa Prefecture, Japan). Despite evidence of PFCs introduced to the 
aquatic environment through runoff, there are limited studies quantifying similar 
contributions of other ECs, such as plasticisers. Furthermore, studies comparing STW 
effluent to runoff contributions of PFCs and plasticisers into the same river system is limited.  
Here, a validated method is presented to accurately and specifically quantify 13 
markers of anthropogenic contamination in fresh water: inter alia pharmaceuticals, illicit 
drugs and their metabolites. Pharmaceuticals and illicit drugs are specific indicators of 
human-derived contamination and improper disposal of drugs, while the plasticisers and 
perfluorinated compounds also indicate contamination from industrial and transport activity 
(street runoff). The presented method can be used to efficiently and specifically quantify 
concentrations of contaminants of human, industrial and transportation origins. A key feature 
of this method is the achievement of adequate detection limits using a relatively small 
amount of water (200mL) for analysis. Here, increased ease of sample transport (due to the 
small volume of water required) enables analysis of a greater number of samples in relatively 
little time. The sensitivity/detection limits of the method proposed as such can be further 
increased by increasing the amount of sample water used in solid phase extraction (SPE). The 
developed method enabled a comparison between contaminant inputs into selected rivers via 
sewage treatment effluent and runoff from both streets and fields.  
 
2. Materials and Methods 
2.1. Standards and Reagents 
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Thirteen compounds were selected for analysis including pharmaceuticals: 
ethinylestradiol, acetaminophen and diclofenac, illicit drugs and metabolites: 
methamphetamine and its metabolite amphetamine and benzoylecgonine (metabolite of 
cocaine), plasticisers: bisphenol-S (BPS), bisphenol-A (BPA) and its biotransformation 
product 4’-hydroxyacetophenone (HAP), perfluorinated compounds: PFOA, PFOS, PFNA, 
and PFBS, and deuterated internal standards: BPA-D16, acetominophen-D4 and 
methamphetamine-D5. All compounds were purchased from Sigma Aldrich (Gillingham, 
Dorset, U.K.) and were of 96% purity or higher. PFOS was purchased as a potassium salt and 
benzoylecgonine was tetrahydrated. Strata-X 33µm polymeric reversed phase 200 mg/6mL 
SPE cartridges were purchased from Phenomenex (Macclesfield, Cheshire, U.K.). A 
Phenomenex Kinetex 2.6u C18 150x2.1mm chromatography column using a SecurityGuard 
ULTRA UHPLC C18 2.1mm guard column was purchased from Phenomenex (Macclesfield, 
Cheshire, U.K.). Whatman GF/F-grade glass microfiber filters (diameter 47mm, pore size 0.7 
µm) were purchased from Fisher Scientific (Loughborough, Leicestershire, U.K.).  
Stock solutions were prepared for each compound and internal standards at a 
concentration of 1000 mg/L in LCMS-grade acetonitrile except for PFOS, diclofenac and 
ethinylestradiol, which were prepared at 1000 mg/L in HPLC grade acetone. A mixed 
solution was made in LCMS-grade acetonitrile to a concentration of 5 mg/L for all analytes 
except BPA at 30 mg/L, ethinylestradiol at 25 mg/L, and HAP at 7.5 mg/L which was further 
diluted into working solutions. Concentrations of target analytes in the mixed solution were 
optimised based on spectrometer sensitivity to each respective compound. Solutions were 
stored in 10mL borosilicate glass volumetric flasks at 4°C in the dark and renewed monthly. 
A mixture of all compounds at 100 ng/L was analysed via HPLC-MS/MS once per week for 
4-weeks to ensure no significant degradation occurred during monthly use of standard 
solutions. 
2.2. Sample Collection 
Effluent samples (n=12) were collected in duplicate from six STWs along three rivers 
in   the south east of England (Hogsmill, Bourne and Blackwater: Supplementary Table 2). 
Runoff samples were collected from grass field drainage (n=3) and street runoff (n=2) during 
periods of rainfall (Supplementary Table 3).  
Grab samples were collected (200 mL) in amber glass bottles. All bottles were washed 
three times with 50/50 acetonitrile:acetone (v/v) followed by three washes with milli-Q water 
and were rinsed with sample water before collection. Water samples were collected from 
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STW effluent outfalls and drainage pipes (both field and street) directly prior to entering the 
river flow. After collection, samples were stored at 4°C in the dark until vacuum filtration 
(within 8 h of collection) using GF/F glass membrane filters. Membrane filters were soaked 
in 10% nitric acid for 12 hours (to degrade any organic compounds within or on the filter) 
followed by three rinses under vacuum filtration with 50:50 acetonitrile:acetone (v/v) and 
three rinses with HPLC water. All samples were extracted before analysis using the SPE 
procedure described in Section 2.3 within 24 h of collection.  
2.3. Solid Phase Extraction 
Solid Phase Extraction (SPE) of 200 mL sample water was carried out using 
Phenomenex Strata-X cartridges preconditioned with 3 mL 50:50 acetonitrile/acetone (v/v), 
washed with 3 mL HPLC-grade H2O and loaded at a rate of 5 mL/min. Loaded cartridges 
were dried under vacuum for 15 min and eluted with 2x7mL aliquots of 50:50 
acetonitrile/acetone (v/v) at a rate of 1 mL/min. Extracts were evaporated to dryness using 
rotary evaporation and reconstituted with 1 mL of  (80:20 HPLC H2O/acetonitrile, v/v) 
spiked with internal standards to 25 ng/mL. 
2.4. HPLC-MS/MS Analysis 
Extracts were analysed by HPLC-MS/MS using an Agilent Technologies 1260 Infinity 
HPLC and an Agilent Technologies 6430 series triple quadrupole mass spectrometer operated 
in multiple reaction monitoring (MRM) mode. Adequate separation was obtained at a flow 
rate of 0.2 mL/min with a solvent gradient starting at 80:20 H2O/acetonitrile (v/v) reducing to 
35:65 H2O/acetonitrile (v/v) at 15 min which returned to 80:20 H2O/acetonitrile (v/v) at 15.1 
min, where it remained until the end of the run at 19.5 min (Figure 1). Collision energy, 
fragmentor and electron multiplier voltage were optimised for two transition ions per target 
analyte and internal standard using electrospray ionisation (Table 1). An electron multiplier 
voltage of +/-350 V was used for every target compound. A capillary voltage of +/-4000 V, 
chamber current of 0.12 µA, nebuliser pressure of 30 psi, gas temperature of 325⁰C and gas 
flow of 12 L/min were used for mass spectrometry. An injection volume of 10 µL was used 
for all analysis. Quantification was achieved using a 9-point blank-offset and internal 
standard-corrected calibration (calibration points also underwent SPE) calculated by linear 
regression analysis in Agilent MassHunter Workstation Software: Quantitative Analysis 
(version B.04.00/Build 4.0.225.19). Calibration standards and blanks also underwent SPE 
and were used to normalise for recoveries. The method was validated using the ICH 
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Harmonised Tripartite Guideline for Validation of Analytical Procedures: Q2(R1) Text and 
Methodology (ICH, 2005). 
2.5. Method Validation and Quality Assurance 
2.5.1 Specificity 
Specificity was assessed by spiking river water collected from the Rowhill Nature 
Reserve (source of the Blackwater River) with a mixture of all selected PPCPs/ECs at a 
concentration of 100 ng/L. Spiked sample chromatograms were compared to those of non-
spiked water samples and assessed for the presence of interfering peaks at the specific 
retention time of known target compounds.  
2.5.2 Intra-/Inter-day Precision/Repeatability 
Repeatability and precision were determined using the relative standard deviation 
(RSD) calculated from replicate extractions of spiked HPLC water subjected to SPE. Intra-
day (intermediate) precision was calculated at two concentrations, 25 ng/L (n=3) and 100 
ng/L (n=3) every day over 3 days (6 determinations/day). Inter-day precision (repeatability) 
was calculated at two concentrations, 25 ng/L (n=6) and 100 ng/L (n=6). Each sample was 
analysed three times by HPLC-MS/MS in triplicate and averages are reported in Table 2. 
2.5.3 Accuracy 
Method accuracy was evaluated by spiking 200 mL HPLC-grade water with a mix of 
analytes at three concentrations followed by solid phase extraction and analysis (triplicate 
analysis, 9 total determinations). Three concentrations of mixed analytes selected were: 10 
ng/L (n=3 replicates), 50 ng/L (n=3 replicates) and 100 ng/L (n=3 replicates). Spiked water 
was subjected to the same treatment as experimental samples (SPE followed by rotary 
evaporation and reconstitution in 1 mL mobile phase before HPLC-MS/MS analysis). 
Replicates were offset by a procedural blank of 200 mL HPLC-water (stored in an identical 
beaker as the accuracy replicates) subjected to SPE, rotary evaporation and reconstitution. 
The absolute value of the difference between the observed/calculated concentrations and the 
known spiked concentration are presented as accuracy (Table 3). 
2.5.4 Recovery 
Recovery was evaluated by spiking 200 mL HPLC-grade water with two 
concentrations of all (mixed) analytes: 50 ng/L (n=3 replicates) and 100 ng/L (n=3 
replicates). Spiked HPLC water was subjected to the same treatment as experimental samples 
(SPE followed by rotary evaporation and reconstitution in 1 mL mobile phase before HPLC-
MS/MS analysis). Samples were analysed in triplicate and analyte concentrations calculated 
using linear regression with calibration points having also undergone SPE. Calculated analyte 
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concentrations were divided by the known spiked concentration and multiplied by 100 to 
yield % recovery (Table 3). HPLC water was selected to evaluate recoveries over spiked 
matrix (STW effluent) due to the high variability of selected contaminant levels found 
between studied STW effluent outfalls.  
2.5.4. Linearity 
Linearity was assessed through calibration curve r2-values using linear regression 
analysis with the aim of attaining r2-values >0.95. Analyte-spiked 200 mL aliquots of HPLC 
water were subjected to SPE followed by rotary evaporation and reconstitution in 1 mL 
mobile phase before HPLC-MS/MS analysis. The spiked HPLC-water concentrations ranged 
from 1-500 ng/L for ethinylestradiol, 0.6-300 ng/L for BPA, 0.3-150 ng/L for HAP and 0.2-
100 ng/L for all other compounds (Supplementary Table 4).  
2.5.5. Limit of detection/quantification 
Both the limit of detection (LOD) and limit of quantification (LOQ) were determined 
using a signal-to-noise approach. A 100 mL aliquot of HPLC-grade water was spiked (pre-
SPE) with analyte masses equal to that in the lowest calibration level (BPA 1.2 ng/L, 
ethinylestradiol 1.0 ng/L, hydroxyacetophenone 0.3 ng/L and all others 0.2 ng/L). SPE 
followed by rotary evaporation and reconstitution in 1mL 80:20 H2O/acetonitrile (v/v) spiked 
with internal standards was conducted prior to HPLC-MS/MS analysis. A total of ten 
replicates were used for the determination of LOD and LOQ. LOD and LOQ were 
determined as the compound’s concentration that yielded a mean signal-to-noise ratio of 3:1 
and 10:1 respectively (n=10). Where such S/N values were not determined at the lowest 
calibration level, identical replicate analysis was performed at increasing concentrations until 
adequate S/N ratios were found (Table 3). 
2.5.6. Calibration and quantitative analysis 
A 9-point internal standard-corrected and blank offset calibration curve was determined 
for each analyte just before field sample extraction and analysis on every sample collection 
day. Calibration points were assessed by spiking 200mL aliquots of HPLC-grade water to the 
concentrations in Supplementary Information Table 4. All calibration and blank samples 
were subjected to the same storage, solid phase extraction, rotary evaporation and 
reconstitution methods/conditions as experimental samples explained in sections 2.2-2.4. 
Using this method, background levels of any potential method-derived contamination was 
offset in each calibration and further offset by a procedural blank. Linear regression analysis 
was performed using Agilent MassHunter Workstation Software: Quantitative Analysis 
(version B.04.00/Build 4.0.225.19). The calibrated range was compound-specific: 1-500 ng/L 
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for ethinylestradiol, 0.6-300 ng/L for BPA, 0.3-150 ng/L for hydroxyacetophenone and 0.2-
100 ng/L for all other compounds (Supplementary Table 4). 
2.5.7 Quality Assurance and Procedural Blanks 
Throughout the development and application of the presented method, great care was 
given to quality, accuracy, and cleanliness. Extracts of environmental samples were always 
injected into the LCMS in triplicate. After every six injections a standard quality control 
SPE-extract (200 mL HPLC-water spiked to 100 ng/L of each analyte) was run to check 
instrument parameters and ensure accurate quantification. All glassware was, without 
exception, rinsed three times with a mixture of acetonitrile:acetone (50:50, v/v) between 
every use except for round bottom flasks used in rotary evaporation which were additionally 
first scrubbed with water and soaked in 10% nitric acid for 16 h between uses. Volumetric 
flasks used to store solutions were dedicated to specific compounds or mixtures as to avoid 
cross-contamination. Laboratory workspaces were cleaned before and after every use and the 
laboratory itself was thoroughly cleaned on a weekly basis. 
Procedural blanks were used throughout method validation and quantitative analysis. 
Blanks underwent the same sample storage, solid phase extraction, rotary evaporation and 
reconstitution as all calibration points and field samples. For example, procedural blanks used 
in calibration and quantitative analysis were created using 200 mL HPLC-water stored in the 
same 3-times solvent rinsed amber glass bottles as field samples and stored in the dark at 4° 
C until solid phase extraction followed by rotary evaporation of SPE extract, reconstitution 
and HPLC-MS/MS analysis. The only difference between these procedural blanks and true 
field blanks was that they did not undergo the sample collection step (capturing of water from 
the effluent outfall). Similarly, the 200 mL HPLC-water used for validation blanks were 
stored in the same solvent rinsed beakers and followed identical handling procedures as 
respective validation replicates (per standard good laboratory practice). Use of blanks in 
method validation followed that outlined in the ICH Q2(R1) Text and Methodology (ICH, 
2005). Analysis was carried out to determine levels of target analytes in blanks relative to a 
calibration of standard samples (not undergoing identical SPE, storage and handling 
procedures). Of the thirteen target contaminants, only two were detected in procedural blanks 
used for quantitative analysis (n=3). Here, BPA was detected below the LOQ and 
hydroxyacetophenone was detected at 1.22 ng/L on average. In procedural blanks used for 
method validation, only hydroxyacetophenone was detected and was consistently found 
below the LOQ (n=3). It should be noted that all calibration points used for quantitative 
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analysis underwent the same handling procedures and sample treatment as field samples and 
were blank offset.  
 
3. Results 
3.1. Method Validation 
Validation results are tabulated in Tables 2 and 3 and a brief description is included in 
this section. 
All intra-day (intermediate precision) RSD-values were below 10% except for 
methamphetamine at 25 ng/L (10.1% on day 3) and 100 ng/L (12.5% day 1 and 13.7% day 
3), acetaminophen at 25 ng/L (12.2% on day 3) and 4’-hydroxyacetophenone at 25 ng/L 
(10.5% day 2 and 12.3% day 3). Inter-day (repeatability) RSD-values were consistently 
below 10% except for methamphetamine at 100 ng/L (11.8%). Table 2 shows average 
repeatability and intra-day precision data. 
Method accuracy was determined to be within ±0.03-2.15 ng/L for all compounds at a 
concentration of 10 ng/L, ±0.66-11.4 ng/L at 50 ng/L and ±0.64-19.8 ng/L for all compounds 
at a 100 ng/L concentration (Table 3). 
Recoveries ranged from 77.6% to 106% at an analyte concentration of 50 ng/L and 
from 80.1% to 114% at 100 ng/L (Table 3). 
Calculated r2-values were consistently above 0.97 indicating a strong linearity for all 
studied compounds over a range of 1-500 µg/L for ethinylestradiol, 0.6-300 µg/L for BPA, 
0.3-150 µg/L for hydroxyacetophenone and 0.2-100 µg/L for all other compounds (Table 3). 
Limits of detection ranged from 0.22 ng/L to 1.17 ng/L (amphetamine and 
ethinylestradiol respectively) and limits of quantification ranged from 0.75 ng/L to 4.91 ng/L 
(PFNA and ethinylestradiol respectively). Limits of detection/quantification are shown in 
Table 3.   
3.2. Occurrence of PPCPs/ECs in Sewage Treatment Effluent 
PPCPs and ECs were identified in every STW effluent (Table 4). It should be noted that 
summary statistics were calculated using all values found above the LOQ. Of the thirteen 
target compounds, eleven were detected in at least one sample, two (amphetamine and 
methamphetamine) were not detected in any sample. Detection frequencies ranged from 25% 
(ethinylestradiol) to 100% (benzoylecgonine, BPA, BPS and diclofenac). Table 4 shows 
concentrations and a basic statistical analysis of PPCPs/ECs detected in STW effluent 
outfalls. Across all studied compounds, the mean detection frequency was 78.5%. BPA was 
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found at a maximum level of 890 ng/L in STW 2 effluent which was significantly higher than 
any other studied compound in STW effluent outfalls (2.72 times higher than the next highest 
concentration).  
Both BPA and its main biodegradation product 4’-hydroxyacetophenone (HAP) were 
typically found at the highest concentrations of any target contaminant in studied STW 
effluent outfalls. Except for STW 1, higher HAP/BPA ratios (possibly indicating greater in-
plant degradation of BPA into HAP) were observed in the effluent outfall of STWs using 
activated sludge treatment (HAP/BPA ratio 1.28-1.52) than STWs using trickling filter 
contact process (HAP/BPA ratio 0.14-0.22). 
Of the pharmaceutical compounds detected, diclofenac was typically found at the 
highest concentration with an average of 62.2 ng/L (1.84 times that of the next highest 
pharmaceutical, acetaminophen). Of the three recreational drugs and urinary metabolites 
thereof, only benzoylecgonine was detected. Benzoylecgonine, a significant urinary 
metabolite of cocaine, was found in 100% of effluent samples with an average concentration 
of 9.20 ng/L. Perfluorinated surfactants were detected with frequencies from 58.3% (PFBS) 
to 91.7% (PFOA and PFNA). PFBS was detected at the highest average level of all PFCs 
(51.3 ng/L) while PFNA was detected at the highest maximum level of the PFCs (209 ng/L in 
STW 4 effluent). 
Daily loads of the compounds detected entering respective rivers via STW effluent 
outfalls (Table 5) ranged from 0.05 g/day (benzoylecgonine in STW 1 first collection) to 22.7 
g/day (BPA in STW 2 second collection). On average, BPA showed the highest daily load 
between all STWs of 6.14 g/day which was 2.68 times that of the next highest, 2.29 g 
HAP/day (BPA’s main biodegradation product). Except for STW 2, total daily loads of 
discharged PPCPs/ECs seemed to be correlated with the population equivalents of the 
respective STW facilities (see Supplementary Table 2 for STW characteristics, Table 5 for 
loads). STWs with higher population equivalents showed greater total daily loads of selected 
contaminants (except for STW 2).  
3.3. Occurrence of PPCPs/ECs in Street and Field Drainage 
Seven of the thirteen compounds monitored were identified in the drainage samples, all 
either plasticisers or PFCs: hydroxyacetophenone, BPS, BPA, PFBS, PFOA, PFNA and 
PFOS (Table 6). Street runoff into the River Bourne and the Blackwater River (inputs 1 and 
2) showed the highest concentrations of target contaminants. Overall, field drainage showed 
both the lowest levels of detected contaminants and the lowest number of detected 
compounds/site (average 4.7 compounds/site detected in field drainage vs 6 compounds/site 
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in street runoff). The highest measured concentration was of BPA (2410 ng/L) in street runoff 
into the River Bourne (Input 1), 2.7 times more concentrated than the highest detected level 
in STW effluent. PFOA and PFNA were also identified at maximum levels of 1160 ng/L and 
647 ng/L in street runoff into the Blackwater River (Input 2) respectively which were 8.52 
(PFOA) and 3.09 (PFNA) times higher than maximum respective levels found in STW 
effluent outfalls. Of the seven compounds detected in field drainage, average concentrations 
were from 3.14 times (BPA) to 24.9 times (PFBS) lower than average concentrations in STW 
effluent.  
Compounds of human origin (pharmaceuticals and residues of recreational drugs) were 
not detected in any field drainage sample. An accurate average discharge volume of each 
drainage input was not possible to determine thus daily loads of detected contaminants were 
not evaluated in sampled runoffs. 
  
4. Discussion and Conclusion 
The presented SPE HPLC-MS/MS method can effectively and specifically quantify 
levels of the selected contaminants in water. The method was validated in-house using the 
ICH Harmonised Tripartite Guideline for Validation of Analytical Procedures: Q2(R1) Text 
and Methodology (ICH, 2005). The presented method demonstrated that pharmaceuticals are 
not the only contaminants of ecological concern entering rivers via STW effluent discharge. 
Specifically, plasticisers and perfluorinated surfactants were detected at similar or higher 
levels than pharmaceuticals in STW effluent discharges. Plasticisers were found to be 
ubiquitous contaminants in all examined discharges into rivers (STW, field, and street 
runoff).  
The type of sewage treatment used appears to have an effect on contaminant effluent 
levels of BPA. Higher ratios of HAP (BPA degradation product) to the BPA parent 
compound (HAP:BPA ratio) may indicate greater in-plant degradation of BPA into HAP. 
HAP:BPA ratios in the effluent of STWs using activated sludge ranged from 1.28 to 1.52 and 
were higher than those observed in plants using trickling filter contact where HAP:BPA 
ratios ranged from 0.14-0.22 (except for STW 2). This finding corroborates those found by 
Barber et al. (2012) where improved removal efficiency of endocrine disrupting compounds 
was observed in a sewage treatment facility in Boulder, Colorado (USA) after an upgrade 
from trickling filter contact to activated sludge treatment. However, contaminants of 
ecological concern are not solely introduced into the aquatic environment via STW effluent 
outfalls.  
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During periods of rainfall, drainage from streets was found to contain PFCs and 
plasticisers at maximum levels, significantly higher (2.7 times for BPA, 3.09 times for PFNA 
and 8.52 times for PFOA) than their maximum levels in STW outfalls. It should be noted that 
the volume of street runoff (introduced into rivers via point-source drainage pipes) is highly 
variable and almost, if not always, exclusively less than the volume of a typical STW effluent 
discharge. Hence, the load of such contaminants entering rivers via street runoff is unknown, 
but may still be influential when considering the great number of such drainage point sources 
(albeit with lower relative flow rates) when compared to the number of STW effluent 
discharges along the course of a river. This is a finding that warrants further investigation.  
Drainage from suburban fields into rivers was also found to contain small amounts of 
plasticisers and PFCs. Average concentrations were 3.14 to 24.9 times lower in field drainage 
than in STW effluent. Relatively low levels of plasticisers and PFCs entering river flow via 
field drainage may be explained by the presence of such chemicals in components of pipes 
used in channelling the discharge into rivers (U.S. Food and Drug Administration, 2015) or 
via their presence in the atmosphere (Huang et al., 2012; Liu et al., 2015). 
Further work is warranted to elucidate the impact of street runoff on levels of 
plasticisers and perfluorinated compounds in receiving rivers. Here, limited samples were 
selected solely as reference to other sources of such contaminants and as a brief comparison 
to levels found in STW effluent discharges. Finding high levels of PFCs and plasticisers in 
street runoff is significant and should be further investigated. A study comparing first-flush 
rainfall discharges with time-weighted averages is particularly worth investigating.  
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6.0 Tables and Figures 
 
Table 1- Ion Fragmentation and Spectrometer Conditions 
 
Compound  Compound Precursor Polarity Quantifier Qualifier  Fragmentor Collision 
Type   Ion Mass 
 
Ion Mass Ion Mass 
 
Energy 
(eV) 
    (amu)   (T1) (T2)   (T1, T2) 
Perfluorinated  PFBS 298.8 Negative 80.0 99.0 128 30, 24 
Compounds PFNA 462.9 Negative 419.0 219.0 92 4, 8 
  PFOA 412.9 Negative 369.0 169.0 100 4, 8 
  PFOS 498.4 Negative 80.0 99.0 180 30, 30 
Pharmaceuticals Acetominophen 152.1 Positive 110.3 65.3 92 12, 30 
  Diclofenac 293.9 Negative 250.0 214.0 56 4, 12 
  Ethinylestradiol 295.5 Positive 133.0 199.5 92 20, 12 
Plasticisers Bisphenol-A 227.1 Negative 212.1 133.1 116 12, 20 
  Bisphenol-S  249.0 Negative 108.1 92.1 132 24, 30 
  4'-Hydroxyacetophenone 135.0 Negative 92.1 120.0 100 24, 12 
Recreational Amphetamine 136.1 Positive 119.1 91.0 66 5, 17 
Drugs Benzoylecgonine 290.1 Positive 168.3 105.2 92 16, 30 
  Methamphetamine  150.1 Positive 91.0 65.1 92 17, 45 
Internal Acetominophen-D4 156.1 Positive 114.4 69.4 100 12, 32 
Standards Bisphenol A-D16 241.1 Negative 141.8 233.0 130 38, 13 
  Methamphetamine-D5 155.1 Positive 121.1 91.1 95 54, 17 
 
T1- Transition ion 1  T2- Transition ion 2 
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Table 2- Intra-/Inter-day Repeatability/Precision 
       Compound Intra-day RSD (%) 
  
  Inter-day RSD (%) 
    25ng/L   
 
100ng/L   25ng/L 100ng/L 
  Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 
 
 
4'-Hydroxyacetophenone 5.92 10.5 12.3 7.47 8.99 4.03 9.57 6.83 
Acetaminophen 5.73 7.4 12.4 6.01 3.82 6.48 8.53 5.44 
Amphetamine 3.91 7.13 5.48 9.48 9.37 5.44 5.51 8.10 
Benzoylecgonine 7.83 10.5 7.99 4.58 3.42 4.14 8.78 4.05 
BPA 5.04 6.56 3.37 3.67 3.43 3.91 4.99 3.67 
BPS 3.06 4.71 4.00 4.10 1.74 4.34 3.92 3.40 
Diclofenac 6.01 6.10 4.75 6.34 4.87 6.66 5.62 5.96 
Ethinylestradiol 9.54 8.57 9.92 9.33 8.59 8.89 9.34 8.94 
Methamphetamine 6.79 9.93 10.1 12.4 9.28 13.7 8.95 11.8 
PFBS 6.65 4.63 9.76 6.62 4.66 7.20 7.01 6.16 
PFNA 2.24 3.15 2.62 3.19 1.77 3.28 2.67 2.75 
PFOA 3.05 4.37 2.78 3.72 2.07 3.74 3.40 3.17 
PFOS 5.64 3.75 6.72 5.11 3.09 2.18 5.37 3.46 
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Table 3- Method validation results 
Compound pKa Accuracy (ng/L) 
 
Recovery (%) Linearity Det./Quant. Limits 
  
 
10ng/L 50ng/L 100ng/L 
 
  LOD LOQ 
    (+/-) (+/-) (+/-) 50ng/L 100ng/L r2-value (ng/L) (ng/L) 
4'-Hydroxyacetophenone 8.12 0.91 3.96 16.8 92.1 83.2 0.987 0.31 1.04 
Acetaminophen 9.38 1.47 4.9 6.71 90.2 93.3 0.973 0.28 0.93 
Amphetamine 10.1 2.15 9.91 16.6 80.2 83.4 0.969 0.22 1.09 
Benzoylecgonine 3.15-9.54 2.1 11.4 19.8 77.2 80.1 0.997 0.31 1.02 
Bisphenol-A 10.3 0.15 2.89 13.9 105 113 0.994 1.17 3.87 
Bisphenol-S 8.2 2.4 11.2 15.7 77.6 84.3 0.993 0.34 3.87 
Diclofenac 4.15 0.41 0.66 4.43 101 104 0.986 0.29 0.96 
Ethinylestradiol 10.7 1.49 5.16 9.67 89.7 90.3 0.971 0.98 4.91 
Methamphetamine 9.87 0.03 3.47 9.68 93.1 90.3 0.988 0.32 1.06 
Perfluorobutanesulfonic Acid <1 1.1 1.84 6.86 103 93.1 0.974 0.33 1.13 
Perfluorononanoic Acid <1 1.13 3.34 0.64 93.3 101 0.993 0.23 0.75 
Perfluorooctanoic Acid <1 1.04 1.63 2.32 103 97.7 0.997 0.34 1.13 
Perfluorooctane Sulfonate <1 1.46 4.97 0.27 90.1 99.7 0.989 0.51 1.52 
 
LOD- Limit of detection, LOQ- Limit of quantification 
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Table 4- STW information and concentrations (ng/L) of PPCPs/ECs detected in STW effluents (n=12) with basic statistical analysis  
 
  
Effluent	
1	
Effluent		
2	
Effluent	
3	
Effluent	
4	
Effluent	
5	
Effluent	
6	
     Population Equivalent 383,000 86,800 37,000 140,000 34,300 88,400 
     Average daily flow (m3) 58,180 25,534 10,073 31,196 9,098 24,795 
     Average flow (m3/sec) 0.673 0.296 0.117 0.361 0.105 0.287 
     Treatment AST AST/TFC* AST AST TFC TFC 
     
Compound (ng/L)             
Mean 
(ng/L) 
Det. Freq. 
(%) Max (ng/L) SD (ng/L) RSD (%) 
4'-Hydroxyacetophenone 13.1 213 150 144 11.8 58.5 98.4 91.7 327 82.8 84.1 
Acetaminophen 17.5 133 17.3 10.3 5.63 19.1 33.8 91.7 157 48.9 145 
Amphetamine ND ND ND ND ND ND ND 0 ND 
 
  
Benzoylecgonine 1.09 19.9 10.8 7 4.61 11.9 9.2 100 25.7 6.57 71.4 
BPA 216 488 98.5 113 82.1 264 210 100 891 154 73.2 
BPS 5.76 201 25 34.2 9.71 4.13 46.5 100 306 76.6 165 
Diclofenac 76.2 31.5 102 98.3 38.9 26.2 62.2 100 201 34.2 55 
Ethinylestradiol ND 5.11 <LOQ 3.75 ND ND 4.43 25 10.2 3.48 78.6 
Methamphetamine ND ND ND ND ND ND ND 0 ND 
 
  
PFBS 9.64 21 57.6 92.3 96 31.3 51.3 58.3 115 36.8 71.7 
PFNA 6.03 5.48 91.9 113 14.9 19.4 41.8 91.7 209 47.8 114 
PFOA 19.9 22.2 21.1 3.89 36.3 87.1 31.7 91.7 136 28.9 91.4 
PFOS 60.1 31.4 22.2 19.8 3.46 56.1 32.2 83.3 115 22.1 68.5 
*Combination of Trickling Filter Contact (TFC) and Activated Sludge Treatment (AST)  ND- Not Detected 
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Table 5- Range of compound loads (g/day) entering receiving rivers via respective STW effluent outfalls (n=12) 
 
  
      
  
Compound (g/day) STW 1 STW 2 STW 3 STW 4 STW 5 STW 6 Mean (g/day) 
4'-Hydroxyacetophenone 0.35-1.17 2.51-8.36 0.03-2.99 ND-9.00 0.03-0.19 0.50-2.40 2.29 
Acetominophen 0.92-1.11 2.80-4.01 0.11-0.24 0.14-0.50 0.01-0.10 ND-2.95 0.91 
Amphetamine ND ND ND ND ND ND 0 
Benzoylecgonine 0.05-0.07 0.36-0.66 0.03-0.18 0.14-0.30 0.02-0.06 0.18-0.41 0.21 
BPA 1.09-24.1 2.17-22.7 0.25-1.74 2.50-4.55 0.20-1.29 5.98-7.09 6.14 
BPS 0.13-0.54 2.46-7.82 0.02-0.49 0.06-2.07 0.01-0.16 0.06-0.14 1.16 
Diclofenac 4.02-4.85 0.09-1.52 0.03-2.02 0.11-6.02 0.14-0.67 0.40-1.30 1.72 
Ethinylestradiol ND ND-0.29 ND ND-0.23 ND ND 0.04 
Methamphetamine ND ND ND ND ND ND 0 
PFBS 0.26-0.86 ND-1.07 ND-1.16 ND-2.88 ND-0.87 ND-1.50 1.03 
PFNA 0.16-0.55 0.07-0.21 0.29-1.56 0.52-6.53 ND-0.14 0.40-0.56 0.93 
PFOA 0.53-1.78 0.26-0.87 0.13-0.29 ND-0.24 0.19-0.47 0.94-3.37 0.76 
PFOS 0.29-6.70 0.10-1.51 ND-0.45 ND-0.62 ND-0.03 0.20-2.59 1.09 
Mean sum of all (g/day) 24.8 29.9 6.01 19.9 2.76 14.3 16.3 
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Table 6- Concentrations of PPCP/ECs detected in street runoff and field drainage prior to entering rivers 
 
Compound Street Runoff (ng/L)  Field Drainage (ng/L) 
  Input 1 Input 2 Input 3 Input 4 Input 5 
4'-Hydroxyacetophenone 48.4 254 5.98 16.5 16.7 
Acetominophen ND ND ND ND ND 
Amphetamine ND ND ND ND ND 
Benzoylecgonine ND ND ND ND ND 
Bisphenol-A 2410 511 54.2 45.6 101 
Bisphenol-S  50.2 40.6 2.27 4.42 159 
Diclofenac ND ND ND ND ND 
Ethinylestradiol ND ND ND ND ND 
Methamphetamine  ND ND ND ND ND 
PFBS 79.1 ND ND ND 6.19 
PFNA 69.2 648 ND 23.0 2.01 
PFOA 6.52 1160 ND 15.5 ND 
PFOS 8.97 ND ND ND 6.57 
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*Quantifying transition ion 
Figure 1- Chromatogram of target PPCP/ECs  
